IPS cells could be used in schizophrenia research

04/14/2011 | MIT Technology Review online

Scientists at the Salk Institute for Biological Studies reported in the journal Nature that they were able to turn skin cells taken from patients with schizophrenia into induced pluripotent stem cells, which were developed into neurons, allowing them to compare neuronal connections between healthy and diseased nerve cells. They think the iPS cells could be used as models that would allow experts to further study the psychiatric illness and test the efficacy of drug candidates for the disease.

View Full Article in:

MIT Technology Review online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD